RATIONALE: Although reactive oxygen species (ROS) are generally considered to be proinflammatory and to contribute to cellular and organ dysfunction when present in excessive amounts, there is evidence that specific ROS, particularly hydrogen peroxide (H(2)O(2)), may have antiinflammatory properties. OBJECTIVES: To address the role that increases in intracellular H(2)O(2) may play in acute inflammatory processes, we examined the effects of catalase inhibition or the absence of catalase on LPS-induced inflammatory responses. METHODS: Neutrophils from control or acatalasemic mice, or control neutrophils incubated with the catalase inhibitor aminotriazole, were treated with LPS, and levels of reactive oxygen species, proteasomal activity, NF-kappaB activation, and proinflammatory cytokine expression were measured. Acute lung injury (ALI) was produced by intratracheal injection of LPS into control, acatalasemic-, or aminotriazole-treated mice. MEASUREMENTS AND MAIN RESULTS: Intracellular levels of H(2)O(2) were increased in acatalasemic neutrophils and in neutrophils exposed to aminotriazole. Compared with LPS-stimulated neutrophils from control mice, neutrophils from acatalasemic mice or neutrophils treated with aminotriazole demonstrated reduced 20S and 26S proteasomal activity, IkappaB-alpha degradation, NF-kappaB nuclear accumulation, and production of the proinflammatory cytokines TNF-alpha and macrophage inhibitory protein (MIP)-2. The severity of LPS-induced ALI was less in acatalasemic mice and in mice treated with aminotriazole as compared with that found in control mice. CONCLUSIONS: These results indicate that H(2)O(2) has antiinflammatory effects on neutrophil activation and inflammatory processes, such as ALI, in which activated neutrophils play a major role.
RATIONALE: Although reactive oxygen species (ROS) are generally considered to be proinflammatory and to contribute to cellular and organ dysfunction when present in excessive amounts, there is evidence that specific ROS, particularly hydrogen peroxide (H(2)O(2)), may have antiinflammatory properties. OBJECTIVES: To address the role that increases in intracellular H(2)O(2) may play in acute inflammatory processes, we examined the effects of catalase inhibition or the absence of catalase on LPS-induced inflammatory responses. METHODS: Neutrophils from control or acatalasemic mice, or control neutrophils incubated with the catalase inhibitor aminotriazole, were treated with LPS, and levels of reactive oxygen species, proteasomal activity, NF-kappaB activation, and proinflammatory cytokine expression were measured. Acute lung injury (ALI) was produced by intratracheal injection of LPS into control, acatalasemic-, or aminotriazole-treated mice. MEASUREMENTS AND MAIN RESULTS: Intracellular levels of H(2)O(2) were increased in acatalasemic neutrophils and in neutrophils exposed to aminotriazole. Compared with LPS-stimulated neutrophils from control mice, neutrophils from acatalasemic mice or neutrophils treated with aminotriazole demonstrated reduced 20S and 26S proteasomal activity, IkappaB-alpha degradation, NF-kappaB nuclear accumulation, and production of the proinflammatory cytokines TNF-alpha and macrophage inhibitory protein (MIP)-2. The severity of LPS-induced ALI was less in acatalasemic mice and in mice treated with aminotriazole as compared with that found in control mice. CONCLUSIONS: These results indicate that H(2)O(2) has antiinflammatory effects on neutrophil activation and inflammatory processes, such as ALI, in which activated neutrophils play a major role.
Authors: T Nishikawa; D Edelstein; X L Du; S Yamagishi; T Matsumura; Y Kaneda; M A Yorek; D Beebe; P J Oates; H P Hammes; I Giardino; M Brownlee Journal: Nature Date: 2000-04-13 Impact factor: 49.962
Authors: Peter E Morris; Peter Papadakos; James A Russell; Richard Wunderink; Daniel P Schuster; Jonathon D Truwit; Jean-Louis Vincent; Gordon R Bernard Journal: Crit Care Med Date: 2008-03 Impact factor: 7.598
Authors: Melissa L T Teoh; Wenqing Sun; Brian J Smith; Larry W Oberley; Joseph J Cullen Journal: Clin Cancer Res Date: 2007-12-15 Impact factor: 12.531
Authors: Amrita Kumar; Huixia Wu; Lauren S Collier-Hyams; Jason M Hansen; Tengguo Li; Kosj Yamoah; Zhen-Qiang Pan; Dean P Jones; Andrew S Neish Journal: EMBO J Date: 2007-10-04 Impact factor: 11.598
Authors: Jaroslaw W Zmijewski; Sami Banerjee; Hongbeom Bae; Arnaud Friggeri; Eduardo R Lazarowski; Edward Abraham Journal: J Biol Chem Date: 2010-08-20 Impact factor: 5.157
Authors: Hong-Beom Bae; Jaroslaw W Zmijewski; Jessy S Deshane; Degui Zhi; Lawrence C Thompson; Cynthia B Peterson; David D Chaplin; Edward Abraham Journal: Am J Respir Cell Mol Biol Date: 2012-01-26 Impact factor: 6.914
Authors: Hong-Beom Bae; Jaroslaw W Zmijewski; Jessy S Deshane; Jean-Marc Tadie; David D Chaplin; Seiji Takashima; Edward Abraham Journal: FASEB J Date: 2011-09-01 Impact factor: 5.191
Authors: Dae Won Park; Shaoning Jiang; Jean-Marc Tadie; William S Stigler; Yong Gao; Jessy Deshane; Edward Abraham; Jaroslaw W Zmijewski Journal: Mol Med Date: 2013-11-08 Impact factor: 6.354
Authors: Brahm H Segal; Wei Han; Jennifer J Bushey; Myungsoo Joo; Zahida Bhatti; Joy Feminella; Carly G Dennis; R Robert Vethanayagam; Fiona E Yull; Maegan Capitano; Paul K Wallace; Hans Minderman; John W Christman; Michael B Sporn; Jefferson Chan; Donald C Vinh; Steven M Holland; Luigina R Romani; Sarah L Gaffen; Michael L Freeman; Timothy S Blackwell Journal: PLoS One Date: 2010-03-16 Impact factor: 3.240
Authors: Sami Banerjee; Jaroslaw W Zmijewski; Emmanuel Lorne; Gang Liu; Yonggang Sha; Edward Abraham Journal: J Biol Chem Date: 2009-11-20 Impact factor: 5.157